Summary of Significant Accounting Policies (Details 3) $ in Thousands	3 Months Ended												12 Months Ended
	Jun. 30, 2015 USD ($)	Mar. 31, 2015 USD ($)	Dec. 31, 2014 USD ($)	Sep. 30, 2014 USD ($)	Jun. 30, 2014 USD ($)	Mar. 31, 2014 USD ($)	Dec. 31, 2013 USD ($)	Sep. 30, 2013 USD ($)	Jun. 30, 2013 USD ($)	Mar. 31, 2013 USD ($)	Dec. 31, 2012 USD ($)	Sep. 30, 2012 USD ($)	Jun. 30, 2015 USD ($) item	Jun. 30, 2014 USD ($)	Jun. 30, 2013 USD ($)
Segment information
Number of reportable segments | item													1
Medical Indication Information
Total	$ 99,276	$ 99,352	$ 114,822	$ 93,387	$ 80,619	$ 79,997	$ 67,326	$ 45,829	$ 40,174	$ 39,022	$ 36,564	$ 35,294	$ 406,837	$ 273,771	$ 151,054
Antibiotic
Medical Indication Information
Total													12,306	13,572	9,167
Cardiovascular
Medical Indication Information
Total													55,166	62,121	25,876
Gallstone
Medical Indication Information
Total													65,262	6,578	6,114
Glaucoma
Medical Indication Information
Total													21,145	11,987	6,410
Gout
Medical Indication Information
Total													6,833	10,822	5,092
Migraine
Medical Indication Information
Total													25,729	14,527	5,418
Muscle Relaxant
Medical Indication Information
Total													8,779
Obesity
Medical Indication Information
Total													4,004	4,032	4,721
Pain Management
Medical Indication Information
Total													27,461	27,174	21,232
Thyroid Deficiency
Medical Indication Information
Total													153,460	102,248	57,978
Other
Medical Indication Information
Total													$ 26,692	$ 20,710	$ 9,046